ANT3310   Click here for help

GtoPdb Ligand ID: 12795

Compound class: Synthetic organic
Comment: ANT3310 is a novel serine β-lactamase inhibitor, belonging to the diazabicyclooctane (DBO) class [1]. It restores the activity of carbapenem antibacterials against carbapenem-resistant Acinetobacter baumannii (CRAB) and is in clinical development in combination with meropenem.
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 2
Topological polar surface area 95.53
Molecular weight 240.21
XLogP -1.65
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES C1C[C@@H](F)N2C[C@@H]1N(C2=O)OS(=O)(=O)O
Isomeric SMILES C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)O)F
InChI InChI=1S/C6H9FN2O5S/c7-5-2-1-4-3-8(5)6(10)9(4)14-15(11,12)13/h4-5H,1-3H2,(H,11,12,13)/t4-,5+/m1/s1
InChI Key GCKKZLXJSUOGES-UHNVWZDZSA-N
No information available.
Summary of Clinical Use Click here for help
ANT3310 in combination with meropenem has been advanced to Phase 1 first-in-human clinical evaluation in healthy subjects (NCT05905913).
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05905913 FiH Study to Assess Safety and PK of SAD and MAD of ANT3310 Alone and in Combination With Meropenem in Healthy Subjects Phase 1 Interventional Antabio